Inventor
BROCKSCHNIEDER DAMIAN
DE11 patents
⚠️ This page may combine multiple inventors who share the name “BROCKSCHNIEDER DAMIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
6 patentsUS9605008B2Mar 28, 2017
Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereof
Bayer Pharma AG3 citations72
US10150773B2Dec 11, 2018
N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (SGC) for the treatment of cardiovascular diseases
Bayer Pharma AG3 citations70
US9688699B2Jun 27, 2017
3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
Bayer Pharma AG1 citations51
US10214526B2Feb 26, 2019
Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof
Bayer Pharma AG0 citations49
US10292970B2May 21, 2019
Heteroaryl-substituted imidazo[1,2-A]pyridines and their use
Bayer Pharma AG0 citations41
US10174021B2Jan 8, 2019
Substituted pyrazolo[1,5-A]pyridines and their use
Bayer Pharma AG0 citations41
BAYER AG
4 patentsUS10722501B2Jul 28, 2020
Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereof
BAYER AG2 citations58
US11337973B2May 24, 2022
Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitors
BAYER AG0 citations46
US12331094B2Jun 17, 2025
Atrial natriuretic peptide engrafted antibodies
BAYER AG0 citations45
US12398120B2Aug 26, 2025
Substituted hydantoinamides as ADAMTS7 antagonists
BAYER AG0 citations43